KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $725,204 | -13.8% | 79,518 | 0.0% | 0.02% | -10.0% |
| Q2 2023 | $841,300 | -13.5% | 79,518 | 0.0% | 0.02% | -31.0% |
| Q1 2023 | $972,505 | +176.0% | 79,518 | +180.0% | 0.03% | +190.0% |
| Q4 2022 | $352,382 | -81.0% | 28,395 | -50.0% | 0.01% | -76.2% |
| Q4 2020 | $1,856,000 | -39.5% | 56,838 | -43.3% | 0.04% | -52.3% |
| Q3 2020 | $3,070,000 | +87.2% | 100,193 | -0.4% | 0.09% | +87.2% |
| Q2 2020 | $1,640,000 | +56.8% | 100,606 | -4.3% | 0.05% | +23.7% |
| Q1 2020 | $1,046,000 | -30.5% | 105,082 | -4.0% | 0.04% | +2.7% |
| Q4 2019 | $1,505,000 | -13.3% | 109,465 | -4.3% | 0.04% | -14.0% |
| Q3 2019 | $1,735,000 | -27.5% | 114,344 | -5.9% | 0.04% | -24.6% |
| Q2 2019 | $2,392,000 | -73.5% | 121,487 | -77.7% | 0.06% | -46.7% |
| Q1 2019 | $9,026,000 | +109.8% | 544,118 | +77.6% | 0.11% | 0.0% |
| Q4 2018 | $4,302,000 | -36.3% | 306,420 | -20.6% | 0.11% | -15.1% |
| Q3 2018 | $6,753,000 | +281.3% | 385,873 | +296.6% | 0.13% | +281.8% |
| Q2 2018 | $1,771,000 | – | 97,294 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |